Details for 2018719162

Up to date per 08.05.2026

Actions

Title / Product Name

KOMBINATIONSTHERAPIE MIT ANTI-AXL-ANTIKÖRPER-ARZNEIMITTEL-KONJUGAT

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018719162

EP Publication Number

3612234

E-Number

1665140

Language

PCT Number

EP18060209

Publication Date

26.02.2020 A

13.03.2024 B1

Registration Date

13.03.2024

AT Publication Date

15.04.2024

Application Date

20.04.2018

Registration Number

Priorities

20.04.2017

201706231

20.04.2017

201706230

20.04.2017

201706229

20.04.2017

201706228

20.04.2017

201706227

20.04.2017

201706226

20.04.2017

201706225

20.04.2017

201706224

20.04.2017

201706223

IPC

A61K 47/68 20170101AFI20181026BHEP

Maximum Duration of Protection

20.04.2038

Owner

ADC Therapeutics SABiopôle Route de la Corniche 3B 1066 EpalingesCH

Medimmune LimitedMilstein Building Granta Park Cambridge, Cambridgeshire CB21 6GHGB

Representative

No representatives present

Inventor

VAN BERKEL, Patricius Hendrikus Cornelisc/o ADC Therapeutics SA Biopôle route de la Corniche 3b 1066 EpalingesCH

WUERTHNER, Jensc/o ADC Therapeutics SA Biopôle route de la Corniche 3b 1066 EpalingesCH

HARTLEY, JohnUCL Cancer Institute Paul O'Gorman Building 72 Huntley Street London Greater London WC1E 6BTGB

ZAMMARCHI, Francescac/o ADC Therapeutics SA Biopôle route de la Corniche 3b 1066 EpalingesCH